DAVID OLIGSCHLAEGER: Open Payments
NPI 1851383418 · SHELBYVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,293 in 67 payments from 16 companies in 2025. Trend: 2023 $1,456 · 2024 $1,450 · 2025 $1,293
Food & beverage: $1,254Education: $39
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $242 |
| ABBVIE INC. | 14 | $222 |
| AstraZeneca Pharmaceuticals LP | 6 | $150 |
| Otsuka America Pharmaceutical, Inc. | 6 | $127 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $89 |
| Neurocrine BioSciences, Inc. | 3 | $71 |
| Abbott Laboratories | 3 | $59 |
| PFIZER INC. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
Products named: VRAYLAR, REXULTI, JARDIANCE, MOUNJARO, BREZTRI, INGREZZA, KISUNLA, NURTEC ODT.
Industry payments across IL — which companies pay providers there.
